Other authors have shown that knockdown of RBP4 significantly reduces ovarian cancer cell migration and proliferation driven through the RhoA/Rock1 and extracellular signal-regulated kinase (ERK) pathways [26]. Here, RHOA is linked to ovarian cancer.